Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: A randomized controlled trial

International Journal of Cardiology

Volumn 158, Issue 1, 2012, Pages 88-92

  Kim, Seung Ju ^a   Kim, Weon ^d   Woo, Jong Shin ^d   Ha, Sang Jin ^d   Kang, Won Yu ^a   Hwang, Sun Ho ^a   Kang, Dong Gu ^b   Lee, Seung Uk ^b   Cho, Sang Ki ^b   Im, Jeong Soo ^c   Kim, Wan ^a  

^a Gwangju Veterans Hospital   (South Korea)

^b Gwangju Christian Hospital   (South Korea)

^c Gachon University   (South Korea)

^d Kyung Hee University College of Medicine   (South Korea)

Author keywords

Adenosine; Coronary intervention; Myocardial infarction; Myonecrosis; Nicorandil

Indexed keywords

ADENOSINE; NICORANDIL;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY STENT; ENZYME BLOOD LEVEL; FEMALE; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; INTRACORONARY INFUSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS; TREATMENT RESPONSE; UNSTABLE ANGINA PECTORIS;

ADENOSINE; AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; HEART DISEASES; HUMANS; INJECTIONS; MALE; MIDDLE AGED; NICORANDIL; PROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 84862012568     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.01.011     Document Type: Article

References (25)

1. L.E. Boodhoo, A.R. Mitchell, J. O'Connor, and NeilSulke Myocardial injury, neurohormonal activation and inflammation after internal atrial defibrillation Int J Cardiol 103 2005 67 72
2. T.Q. Kong, C.J. Davidson, S.N. Meyers, J.T. Tauke, M.A. Parker, and R.O. Bonow Prognostic implication of creatine kinase elevation following elective coronary artery interventions JAMA 277 1997 461 466
3. J.P. Ioannidis, E. Karvouni, and D.G. Katritsis Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention J Am Coll Cardiol 42 2003 1406 1411
4. M.J. Ricciardi, C.J. Davidson, and G. Gubernikoff Troponin I elevation and cardiac events after percutaneous coronary intervention Am Heart J 145 2003 522 528
5. M.J. Ricciardi, E. Wu, and C.J. Davidson Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation Circulation 103 2001 2780 2783
6. J.W. Choi, C.M. Gibson, S.A. Murphy, C.J. Davidson, R.J. Kim, and M.J. Ricciardi Myonecrosis following stent placement: association between impared TIMI myocardial perfusion grade and MRI visualization of microinfarcion Catheter Cardiovasc Interv 61 2004 472 476
7. K.W. Mahaffey, J.A. Puma, and N.A. Barbagelata Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial J Am Coll Cardiol 34 1999 1711 1720
8. M. Marzilli, E. Orsini, P. Marraccini, and R. Testa Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction Circulation 101 2000 2154 2159
9. A.M. Ross, R.J. Gibbons, G.W. Stone, R.A. Kloner AMISTAD-II Investigators A randomized, double-blinded, placebo-controlled multi-center trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II) J Am Coll Cardiol 45 2005 1775 1780
10. H. Ito, Y. Taniyama, and K. Iwakura Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction J Am Coll Cardiol 33 1999 654 660
11. D.J. Patel, H.J. Purcell, and K.M. Fox Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil: CESAR 2 investigation: clinical European studies in angina and revascularization Eur Heart J 20 1999 51 57
12. T. Isono, H. Kamihata, and Y. Sutani Nicorandil suppressed myocardial injury after percutaneous coronary intervention Int J Cardiol 123 2008 123 128
13. C.H. Lee, A. Low, and B.C. Tai Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention Eur Heart J 28 2007 19 25
14. L.W. Klein, B.L. Kramer, E. Howard, and M. Lesch Incidence and clinical signigicance of transient creatine kinase elevations and the diagnosis of non Q-wave myocardial infarction associated with coronary angioplasty J Am Coll Cardiol 17 1991 621 626
15. J.K. Oh, C. Shub, D.M. IIstrup, and G.S. Reeder Creatine kinase release after successful percutaneous transluminal coronary angioplasty Am Heart J 109 1985 1225 1231
16. W.J. Cantor, L.K. Newby, and R.H. Christenson Prognostic significance of elevated troponin I after percutaneous coronary intervention J Am Coll Cardiol 39 2002 1738 1744
17. B.E. Tardiff, R.M. Califf, and J.E. Tcheng Clinical outcomes after detection of elevated cardiac enzymes in patinets undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II J Am Coll Cardiol 33 1999 88 96
18. M.A. Leesar, M. Stoddard, M. Ahmed, J. Broadbent, and R. Bolli Preconditioning of human myocardium with adenosine during coronary angioplasty Circulation 95 1997 2500 2507
19. N. Taira Nicorandil as a hybrid between nitrates and potassium channel activators Am J Cardiol 63 1989 18J 24J
20. K. Akai, Y. Wang, and K. Sato Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels J Cardiovasc Pharmacol 26 1995 541 547
21. The IONA Study group Effect of nicorandil on coronary events in patients with stable angina: the Impact of Nicorandil in Angina (IONA) randomized trial Lancet 359 2002 1269 1275
22. G. Di Sciascio, G. Patti, V. Pasceri, G. Colonna, F. Mangiacapra, A. Montinaro on behalf of the ARMYDA-4 RELOAD investigators Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial Eur Heart J 31 2010 1337 1343
23. G. Patti, G. Colonna, V. Pasceri, L.L. Pepe, A. Montinaro, and G. Di Sciascio Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study Circulation 111 2005 2099 2106
24. V. Pasceri, G. Patti, A. Nusca, C. Pristipino, G. Richichi ARMYDA Investigators Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study Circulation 110 2004 674 678
25. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2